Clinical Trial Update: A Study of the Presillion Stent in de Novo Coronary Lesions [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the Presillion Stent for de novo coronary lesions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Presillion Stent (stent)

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED